We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Vitamin B3 Reverses Effects of Fetal Alcohol Syndrome

By Biotechdaily staff writers
Posted on 02 Mar 2006
A form of vitamin B3 called nicotinamide has been shown to reverse the molecular, cellular, and behavioral effects of fetal alcohol syndrome (FAS) in mice, according to a new study.

The study, published in the February 21, 2006, issue of the journal PLoS Medicine, suggests that nicotinamide may have potential as a preventative therapy in the treatment of FAS in humans. More...
These findings may also have implications for children born with other neurologic disorders such as cerebral palsy.

"Despite attempts to increase awareness of FAS, consumption of alcohol during pregnancy, especially binge drinking, has increased in recent years and currently there are no effective treatments to prevent or revert the devastating effects of FAS. Our findings offer hope that nicotinamide may fill this need,” stated Dr. Daniel Herrera, assistant professor of psychiatry at Weill Medical College of Cornell University (New York, NY, USA).

Ethanol and nicotinamide were administered to seven-day-old postnatal mice, an age at which the brain development of mice is comparable to the human third trimester. The study found that most damage occurred in brain areas that are especially sensitive to ethanol during development, such as the anterior cingulate cortex (involved in cognition), hippocampus (needed for learning and memory), and thalamus (relays sensory information to other brain areas). Nicotinamide treatment decreased this damage. Several days following ethanol exposure, the research demonstrated reduced numbers of neurons (compared with the control brains) in similar brain regions. Again, nicotinamide reduced ethanol's effects.

Lastly, the researchers used three standard behavioral tests to determine whether the reduction in ethanol-induced neuronal death produced by nicotinamide affected the behavior of adult mice. They reported that nicotinamide reversed the increase in hyperactivity and the decrease in fear caused by ethanol exposure, and prevented the impairment in learning and memory induced by ethanol.

Whereas the beneficial effects noted were most evident when nicotinamide was given at the same time or shortly after alcohol exposure, the study suggests that there is a time period of a few hours during which treatment with nicotinamide might be effective.

FAS is estimated to be the most common, preventable cause of mental retardation in the western world. About one in 1,000 U.S. children is born with FAS. Children with FAS characteristically have abnormal facial features and reduced growth. They also have central nervous system abnormalities that lead to impaired learning and memory skills, hyperactivity, and other behavioral problems. These neurologic disabilities arise because ethanol disrupts the formation and survival of neurons in the developing brain, particularly in the last trimester of pregnancy and the first few years of postnatal life when brain development is principally active.

Nicotinamide and other forms of vitamin B3 have been used for many years as dietary supplements to treat and prevent pellagra, a vitamin deficiency disease. Large oral doses of nicotinamide have also been used in clinical trials to treat type I diabetes and bullous pemphigoid (a chronic, autoimmune skin-blistering disease). Furthermore, recent animal research indicates that nicotinamide is also neuroprotective. Nicotinamide has little or no side effects and results in no birth defects.



Related Links:
Weill Medical College of Cornell University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Platelet Function Analyzer
PL-12
Immunofluorescence Analyzer
IFA System
New
Gastrointestinal Panel
Xpert® GI Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

New Insights Into Fetal DNA Could Improve Non-Invasive Prenatal Testing

Non-invasive prenatal testing is widely used to screen pregnancies for genetic conditions by analyzing DNA fragments in maternal blood. Although it offers a safer alternative to invasive procedures such... Read more

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.